Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Nov-22 5:03 PM View:  | Venus Concept Inc. (VERO) | 18-Nov-22 | Private Purchase | 1,250,000 | $0.20 | $250,000.00 | 100% 0 to 1.25M | |
| 22-Mar-16 4:10 PM View: | Endo International plc (ENDP) | 21-Mar-16 | Payment of Exercise | 28,099 | $29.78 | $836,788.00 | (4%) 769.69K to 741.59K | 77% |
| 22-Mar-16 4:10 PM View: | Endo International plc (ENDP) | 21-Mar-16 | Option Exercise | 61,636 | -- | -- | 9% 708.06K to 769.69K | |
| 22-Mar-16 4:10 PM View: | Endo International plc (ENDP) | 21-Mar-16 | Option Exercise | 82,182 | -- | -- | (11%) 741.59K to 659.41K | |
| 22-Mar-16 4:10 PM View: | Endo International plc (ENDP) | 18-Mar-16 | Payment of Exercise | 6,244 | $30.43 | $190,005.00 | (1%) 549.94K to 543.69K | 78% |
| 07-Mar-16 3:57 PM View: | Endo International plc (ENDP) | 07-Mar-16 | Market Purchase | 2,250 | $44.50 | $100,125.00 | < 1% 311.77K to 314.02K | (85%) |
| 04-Mar-16 4:43 PM View: | Endo International plc (ENDP) | 02-Mar-16 | Payment of Exercise | 56,198 | $43.06 | $2,419,890.00 | (7%) 836.73K to 780.54K | 84% |
| 04-Mar-16 4:43 PM View: | Endo International plc (ENDP) | 02-Mar-16 | Option Exercise | 123,273 | -- | -- | 17% 713.46K to 836.73K | |
| 04-Mar-16 4:43 PM View: | Endo International plc (ENDP) | 02-Mar-16 | Option Exercise | 82,182 | -- | -- | (11%) 780.54K to 698.35K | |
| 25-Feb-16 8:15 PM View: | Endo International plc (ENDP) | 23-Feb-16 | Grant | 149,342 | -- | -- | 26% 564.12K to 713.46K | |
| 12-Nov-15 7:33 AM View: | Endo International plc (ENDP) | 11-Nov-15 | Market Purchase | 9,006 | $55.52 | $500,013.00 | 4% 249.39K to 258.39K | (88%) |
| 26-Feb-15 7:53 PM View: | Endo International plc (ENDP) | 24-Feb-15 | Grant | 69,290 | -- | -- | 28% 250.13K to 319.42K | |
| 05-Jan-15 5:24 PM View: | Endo International plc (ENDP) | 31-Dec-14 | Payment of Exercise | 6,244 | $72.90 | $455,188.00 | (3%) 178.62K to 172.37K | 91% |
| 15-Sep-14 7:26 PM View: | Endo International plc (ENDP) | 02-Sep-14 | Grant | 85,770 | -- | -- | 52% 164.36K to 250.13K | |
| 03-Mar-14 4:15 PM View: | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 164,921 | -- | -- | (39%) 419.99K to 255.07K | |
| 03-Mar-14 4:15 PM View: | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 63,315 | -- | -- | (25%) 255.07K to 191.76K | |
| 03-Mar-14 4:15 PM View: | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 191,758 | -- | -- | (100%) 191.76K to 0 | |
| 04-Mar-14 6:45 PM View: | Endo International plc (ENDP) | 28-Feb-14 | Grant | 164,921 | -- | -- | (201%) (-82.18K) to 82.74K | |
| 04-Mar-14 6:45 PM View: | Endo International plc (ENDP) | 28-Feb-14 | Grant | 63,315 | -- | -- | 77% 82.74K to 146.05K | |
| 04-Mar-14 6:45 PM View: | Endo International plc (ENDP) | 28-Feb-14 | Grant | 191,758 | -- | -- | 131% 146.05K to 337.81K | |
| 02-Jan-14 8:38 PM View: | Endo Pharmaceuticals Holdin... (ENDP) | 31-Dec-13 | Payment of Exercise | 7,179 | $67.29 | $483,075.00 | (4%) 172.1K to 164.92K | 84% |
| 08-Jan-13 6:45 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-Jan-13 | Payment of Exercise | 5,450 | -- | -- | (2%) 265.22K to 259.77K | |
| 09-Nov-12 3:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Nov-12 | Option Exercise | 76,344 | $25.42 | $1,940,660.00 | 29% 265.22K to 341.56K | |
| 09-Nov-12 3:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Nov-12 | Market Option Sale | 76,344 | $54.04 | $4,125,680.00 | (22%) 341.56K to 265.22K | 56% |
| 08-Nov-12 4:40 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Nov-12 | Option Exercise | 220,694 | $11.89 | $2,623,150.00 | 83% 265.22K to 485.91K | |
| 08-Nov-12 4:40 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Nov-12 | Market Option Sale | 220,694 | $54.38 | $12,000,800.00 | (45%) 485.91K to 265.22K | 56% |
| 08-Nov-12 4:40 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Nov-12 | Market Sale | 2 | $54.38 | $108.75 | (< 1%) 265.22K to 265.22K | 56% |
| 26-Oct-12 4:11 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Oct-12 | Payment of Exercise | 955 | -- | -- | (< 1%) 266.17K to 265.22K | |
| 28-Sep-12 4:39 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Sep-12 | Payment of Exercise | 40,766 | -- | -- | (13%) 306.94K to 266.17K | |
| 28-Sep-12 4:39 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Sep-12 | Option Exercise | 87,952 | -- | -- | 40% 218.99K to 306.94K | |
| 27-Jul-12 2:18 PM View: | Valeant Pharmaceuticals Int... (BHC) | 25-Jul-12 | Payment of Exercise | 2,293 | -- | -- | (1%) 221.28K to 218.99K | |
| 29-May-12 1:53 PM View: | AMAG Pharmaceuticals, Inc. (AMAG) | 24-May-12 | Purchase | 14,822 | -- | -- | 100% 0 to 14.82K | |
| 09-Jan-12 5:42 PM View: | Valeant Pharmaceuticals Int... (BHC) | 05-Jan-12 | Payment of Exercise | 12,364 | -- | -- | (5%) 247.94K to 235.57K | |
| 26-Oct-11 5:05 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Oct-11 | Grant | 6,180 | -- | -- | 3% 241.76K to 247.94K | |
| 22-Feb-12 5:59 PM View: | Valeant Pharmaceuticals Int... (BHC) | 23-Sep-11 | Payment of Exercise | 6,957 | -- | -- | (3%) 228.24K to 221.28K | |
| 22-Feb-12 5:59 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Sep-11 | Payment of Exercise | 7,336 | -- | -- | (3%) 235.57K to 228.24K | |
| 16-Aug-11 4:43 PM View: | Valeant Pharmaceuticals Int... (BHC) | 12-Aug-11 | Market Purchase | 6,180 | $40.40 | $249,666.00 | 3% 235.58K to 241.76K | (42%) |
| 27-Jul-11 4:19 PM View: | Valeant Pharmaceuticals Int... (BHC) | 25-Jul-11 | Grant | 51,644 | -- | -- | 23% 220.74K to 272.38K | |
| 03-Jun-11 6:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Jun-11 | Payment of Exercise | 31,442 | $52.36 | $1,646,300.00 | (6%) 490.86K to 459.41K | 55% |
| 03-Jun-11 6:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Jun-11 | Option Exercise | 69,581 | $8.11 | $564,302.00 | 17% 421.27K to 490.86K | |
| 02-Dec-10 9:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Dec-10 | Option Exercise | 18,277 | $8.11 | $148,226.00 | 4% 493.41K to 511.69K | |
| 02-Dec-10 9:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Dec-10 | Market Option Sale (Planned) | 18,277 | $27.00 | $493,479.00 | (4%) 511.69K to 493.41K | 14% |
| 02-Dec-10 9:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Dec-10 | Market Sale (Planned) | 201,620 | $27.00 | $5,443,740.00 | (41%) 493.41K to 291.79K | 14% |
| 20-Oct-10 6:00 PM View: | Valeant Pharmaceuticals Int... (VRX) | 28-Sep-10 | Disposition | 261,994 | -- | -- | (100%) 261.99K to 0 | |
| 30-Sep-10 9:25 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Sep-10 | Grant | 484,239 | -- | -- | 100% 0 to 484.24K | |
| 24-Aug-10 7:29 PM View: | Valeant Pharmaceuticals Int... (VRX) | 24-Aug-10 | Payment of Exercise | 2,387 | $57.02 | $136,107.00 | (2%) 96.49K to 94.1K | (2%) |
| 11-Jun-10 5:57 PM View: | Valeant Pharmaceuticals Int... (VRX) | 09-Jun-10 | Option Exercise | 23,000 | $22.68 | $521,640.00 | 24% 96.49K to 119.49K | |
| 11-Jun-10 5:57 PM View: | Valeant Pharmaceuticals Int... (VRX) | 09-Jun-10 | Market Option Sale | 23,000 | $45.24 | $1,040,570.00 | (19%) 119.49K to 96.49K | (29%) |
| 22-Jan-10 2:21 PM View: | Valeant Pharmaceuticals Int... (VRX) | 21-Jan-10 | Payment of Exercise | 2,143 | $34.27 | $73,440.60 | (2%) 98.63K to 96.49K | (70%) |
| 14-Sep-09 2:58 PM View: | Valeant Pharmaceuticals Int... (VRX) | 10-Sep-09 | Grant | 9,007 | -- | -- | 9% 98.63K to 107.64K |